{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:13:48Z","timestamp":1791843228381,"version":"4.3.4"},"reference-count":196,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.autrev.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T17:05:45Z","timestamp":1499533545000},"page":"885-896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":229,"title":["Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases"],"prefix":"10.1016","volume":"16","author":[{"given":"You","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.07.002_bb0005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.21.10.870","article-title":"Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology","volume":"21","author":"Chapman","year":"1980","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2017.07.002_bb0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.22042","article-title":"The causes of primary biliary cirrhosis: Convenient and inconvenient truths","volume":"47","author":"Gershwin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0020","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.07.002_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOG.0000000000000333","article-title":"The evolution of natural history of primary sclerosing cholangitis","volume":"33","author":"Takakura","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2016.10.003","article-title":"Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis","volume":"77","author":"Chung","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.07.002_bb0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2017.07.002_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cld.2015.08.005","article-title":"Primary sclerosing cholangitis: multiple phenotypes, multiple approaches","volume":"20","author":"Sarkar","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.autrev.2017.07.002_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.02.004","article-title":"Checkpoint-based immunotherapy for autoimmune diseases - opportunities and challenges","volume":"79","author":"He","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.07.002_bb0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S2468-1253(16)30010-3","article-title":"Advances in primary sclerosing cholangitis","volume":"1","author":"Horsley-Silva","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2015.08.016","article-title":"Using GWAS to identify genetic predisposition in hepatic autoimmunity","volume":"66","author":"Webb","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.07.002_bb0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2015.07.004","article-title":"The immunogenetics of primary biliary cirrhosis: a comprehensive review","volume":"64","author":"Webb","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.07.002_bb0065","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3748\/wjg.v22.i1.338","article-title":"Xenobiotics and loss of tolerance in primary biliary cholangitis","volume":"22","author":"Wang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12016-014-8419-x","article-title":"Genetics in PBC: what do the \"risk genes\" teach us?","volume":"48","author":"Hirschfield","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-015-8516-5","article-title":"The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis","volume":"50","author":"Yang","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0080","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/liv.13344","article-title":"Finding the cure for primary biliary cholangitis - still waiting","volume":"37","author":"Tanaka","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2017.07.002_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0035-1571273","article-title":"Primary biliary cirrhosis beyond ursodeoxycholic acid","volume":"36","author":"Corpechot","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2017.07.002_bb0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0035-1571274","article-title":"New therapeutic strategies for primary sclerosing cholangitis","volume":"36","author":"Williamson","year":"2016","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.autrev.2017.07.002_bb0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/2040622315605821","article-title":"A review of the medical treatment of primary sclerosing cholangitis in the 21st century[J]","volume":"7","author":"Goode","year":"2016","journal-title":"Therapeutic advances in chronic disease"},{"key":"10.1016\/j.autrev.2017.07.002_bb0100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1042\/cs0950637","article-title":"Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis?","volume":"95","author":"Pereira","year":"1998","journal-title":"Clin Sci"},{"key":"10.1016\/j.autrev.2017.07.002_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2015.08.012","article-title":"The gut-liver axis in primary sclerosing cholangitis","volume":"20","author":"Eksteen","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.autrev.2017.07.002_bb0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.autrev.2014.10.013","article-title":"The intestinal microbiota and microenvironment in liver","volume":"14","author":"Ma","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.002_bb0115","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","article-title":"The interaction between bacteria and bile","volume":"29","author":"Begley","year":"2005","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.autrev.2017.07.002_bb0120","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.autrev.2017.07.002_bb0125","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.1840120523","article-title":"Hepatic injury induced by bile salts: correlation between biochemical and morphological events","volume":"12","author":"Schmucker","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0130","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jhep.2015.08.001","article-title":"Implications of microbiota and bile acid in liver injury and regeneration","volume":"63","author":"Liu","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0135","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0140","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0022-2275(20)30272-8","article-title":"Nuclear receptor-mediated repression of human cholesterol 7\u03b1-hydroxylase gene transcription by bile acids","volume":"42","author":"Chen","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.autrev.2017.07.002_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","article-title":"Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis","volume":"178","author":"Allen","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0150","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.20246","article-title":"Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways","volume":"39","author":"Schoemaker","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0155","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0005-2728(98)00112-1","article-title":"The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy","volume":"1366","author":"Lemasters","year":"1998","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"10.1016\/j.autrev.2017.07.002_bb0165","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/1566524033479555","article-title":"Death receptor activation-induced hepatocyte apoptosis and liver injury","volume":"3","author":"Yin","year":"2003","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.autrev.2017.07.002_bb0170","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","article-title":"Endoplasmic reticulum stress in liver disease","volume":"54","author":"Malhi","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI4765","article-title":"Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas","volume":"103","author":"Faubion","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.07.002_bb0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/toxsci\/kfi012","article-title":"Signaling modulation of bile salt-induced necrosis in isolated rat hepatocytes","volume":"83","author":"Borgognone","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.autrev.2017.07.002_bb0185","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/152308602760598918","article-title":"Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy","volume":"4","author":"Lemasters","year":"2002","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.autrev.2017.07.002_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1172\/JCI116546","article-title":"Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium","volume":"92","author":"Spivey","year":"1993","journal-title":"J Clin Investig"},{"key":"10.1016\/j.autrev.2017.07.002_bb0195","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO3\u2212 umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3\u2212 umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000324144","article-title":"Role of the anion exchanger 2 in the pathogenesis and treatment of primary biliary cirrhosis","volume":"29","author":"Medina","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.autrev.2017.07.002_bb0210","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaut.2016.08.006","article-title":"Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis","volume":"75","author":"Hisamoto","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.07.002_bb0215","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90780","article-title":"Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response","volume":"2","author":"Cai","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2017.07.002_bb0220","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.4049\/jimmunol.176.12.7189","article-title":"Biliary obstruction selectively expands and activates liver myeloid dendritic cells","volume":"176","author":"Bleier","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0225","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ajpath.2013.07.019","article-title":"IL-17A synergistically enhances bile acid\u2013induced inflammation during obstructive cholestasis","volume":"183","author":"O'Brien","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0230","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.autrev.2017.07.002_bb0235","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","article-title":"Molecular pathogenesis of cholestasis","volume":"339","author":"Trauner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.002_bb0240","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/mp060010s","article-title":"Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations","volume":"3","author":"Zollner","year":"2006","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.autrev.2017.07.002_bb0245","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/j.gastro.2011.02.044","article-title":"Nuclear receptors as new perspective for the management of liver diseases","volume":"140","author":"Trauner","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/03602532.2012.740048","article-title":"Nuclear receptors in bile acid metabolism","volume":"45","author":"Li","year":"2013","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.autrev.2017.07.002_bb0255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/MIB.0b013e318286ff2e","article-title":"Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia","volume":"19","author":"Torres","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.autrev.2017.07.002_bb0260","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","article-title":"Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis","volume":"142","author":"Modica","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0265","doi-asserted-by":"crossref","first-page":"41334","DOI":"10.1074\/jbc.M112.421834","article-title":"Nuclear receptors HNF4\u03b1 and LRH-1 cooperate in regulating Cyp7a1 in vivo","volume":"287","author":"Kir","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.07.002_bb0270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2017.07.002_bb0275","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0280","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.07.002_bb0285","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor","volume":"277","author":"Kast","year":"2002","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.autrev.2017.07.002_bb0290","doi-asserted-by":"crossref","first-page":"G1124","DOI":"10.1152\/ajpgi.00539.2005","article-title":"Upregulation of a basolateral FXR-dependent bile acid efflux transporter OST\u03b1-OST\u03b2 in cholestasis in humans and rodents","volume":"290","author":"Boyer","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0295","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0300","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbalip.2010.04.006","article-title":"Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease","volume":"1801","author":"Gadaleta","year":"2010","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.autrev.2017.07.002_bb0305","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.4049\/jimmunol.0901347","article-title":"The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis","volume":"183","author":"Mencarelli","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0310","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0315","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbagrm.2014.05.021","article-title":"Bile acid signaling and liver regeneration","volume":"1849","author":"Fan","year":"2015","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"10.1016\/j.autrev.2017.07.002_bb0320","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/hep.22221","article-title":"Mechanisms of hepatocyte growth factor\u2013mediated and epidermal growth factor\u2013mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium","volume":"47","author":"Limaye","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0325","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12016-014-8443-x","article-title":"TGR5: pathogenetic role and\/or therapeutic target in fibrosing cholangitis?","volume":"48","author":"Keitel","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0330","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/hep.28707","article-title":"G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice","volume":"65.3","author":"Donepudi","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0335","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-\u03baB) in mice","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0340","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2017.07.002_bb0345","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clinre.2012.03.008","article-title":"Perspective: TGR5 (Gpbar-1) in liver physiology and disease","volume":"36","author":"Keitel","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.apsb.2015.01.009","article-title":"Bile acid signaling and biliary functions","volume":"5","author":"Jones","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.autrev.2017.07.002_bb0355","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/liv.13294","article-title":"Old and new treatments for primary biliary cholangitis","volume":"37","author":"Chascsa","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2017.07.002_bb0360","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","article-title":"Assessment of biliary bicarbonate secretion in humans by positron emission tomography","volume":"117","author":"Prieto","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0365","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","article-title":"A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation","volume":"101","author":"Rodrigues","year":"1998","journal-title":"J Clin Investig"},{"key":"10.1016\/j.autrev.2017.07.002_bb0370","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.1840110104","article-title":"Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"11","author":"Calmus","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0375","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1756283X16630712","article-title":"Novel bile acid therapeutics for the treatment of chronic liver diseases","volume":"9","author":"Hegade","year":"2016","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0380","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/jm025529g","article-title":"6\u03b1-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity","volume":"45","author":"Pellicciari","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.autrev.2017.07.002_bb0385","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12016-014-8456-5","article-title":"New therapies for primary biliary cirrhosis","volume":"48","author":"Floreani","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0390","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.002_bb0395","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/HMER.S91709","article-title":"Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection","volume":"8","author":"Bowlus","year":"2016","journal-title":"Hepat Med"},{"key":"10.1016\/j.autrev.2017.07.002_bb0400","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.autrev.2016.07.003","article-title":"Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach","volume":"15","author":"Mousa","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.002_bb0405","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-0036-1597929","article-title":"Novel treatment strategies for primary biliary cholangitis","volume":"37","author":"Pares","year":"2017","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2017.07.002_bb0410","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2015.10.024","article-title":"Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis","volume":"64","author":"Baghdasaryan","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0415","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2016.08.017","article-title":"Metabolic preconditioning protects BSEP\/ABCB11\u2212\/\u2212 mice against cholestatic liver injury","volume":"66","author":"Fuchs","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.autrev.2017.07.002_bb0420","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.28991","article-title":"New therapeutic concepts in bile acid transport and signaling for management of cholestasis","volume":"65","author":"Trauner","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0425","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.07.002_bb0430","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.07.002_bb0435","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Le Chatelier","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.07.002_bb0440","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1890\/04-0922","article-title":"Effects of biodiversity on ecosystem functioning: a consensus of current knowledge","volume":"75","author":"Hooper","year":"2005","journal-title":"Ecol Monogr"},{"key":"10.1016\/j.autrev.2017.07.002_bb0445","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","article-title":"Gut microbiome and liver diseases","volume":"65","author":"Tilg","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2017.07.002_bb0450","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2016.06.009","article-title":"A clinical update on the significance of the gut microbiota in systemic autoimmunity","volume":"74","author":"Rosser","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.07.002_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2017.03.009","article-title":"Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases","author":"Chen","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.07.002_bb0460","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.autrev.2016.07.012","article-title":"Microbiota at the crossroads of autoimmunity","volume":"15","author":"Shamriz","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.002_bb0465","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.autrev.2015.07.007","article-title":"Rheumatoid arthritis-celiac disease relationship: joints get that gut feeling","volume":"14","author":"Lerner","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.002_bb0470","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jju023","article-title":"The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II","author":"Rossen","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2017.07.002_bb0475","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/1462-2920.13401","article-title":"Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis","volume":"18","author":"Lv","year":"2016","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","author":"Tang","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2017.07.002_bb0485","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/hep.1840130425","article-title":"Biliary tract disease in rats with experimental small bowel bacterial overgrowth","volume":"13","author":"Lichtman","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0490","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF02365447","article-title":"Small duct cholangitis induced byn-formyll-methioninel-leucinel-tyrosine in rats","volume":"29","author":"Yamada","year":"1994","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0495","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/labinvest.2010.40","article-title":"Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation","volume":"90","author":"Haruta","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2017.07.002_bb0500","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","volume":"63","author":"Tabibian","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0505","series-title":"The microbiome and primary sclerosing cholangitis. seminars in liver disease","first-page":"340","author":"Ali","year":"2016"},{"key":"10.1016\/j.autrev.2017.07.002_bb0510","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0036-1594006","article-title":"Primary biliary cirrhosis and the microbiome","volume":"36","author":"Quigley","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2017.07.002_bb0515","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2016-312137","article-title":"Primary sclerosing cholangitis: 50years of a gut\u2013liver relationship and still no love?","author":"Karlsen","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2017.07.002_bb0520","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.07.002_bb0525","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","article-title":"Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis","volume":"118","author":"Rakoff-Nahoum","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2017.07.002_bb0530","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/00365521.2014.913189","article-title":"Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies","volume":"49","author":"Tabibian","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0535","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.07.002_bb0540","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20041035","article-title":"Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis","volume":"200","author":"Eksteen","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.07.002_bb0545","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26702","article-title":"CD8 T cells primed in the gut-associated lymphoid tissue induce immune-mediated cholangitis in mice","volume":"59","author":"Seidel","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2015.08.009","article-title":"The critical role of toll-like receptors\u2013from microbial recognition to autoimmunity: a comprehensive review","volume":"15","author":"Jimenez-Dalmaroni","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.002_bb0555","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.3748\/wjg.v18.i48.7141","article-title":"Role of autoimmunity in primary biliary cirrhosis","volume":"18","author":"Shi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0560","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.28641","article-title":"Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance","volume":"64","author":"Bae","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.autrev.2017.07.002_bb0565","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/hep.29059","article-title":"The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis","volume":"65","author":"Shuai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0570","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/hep.27313","article-title":"Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis","volume":"60","author":"Zhang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0575","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/17474124.2017.1293524","article-title":"Emerging treatments for primary sclerosing cholangitis","volume":"11","author":"Rodriguez","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0580","series-title":"Breach of tolerance: primary biliary cirrhosis. Seminars in liver disease","first-page":"297","author":"Wang","year":"2014"},{"key":"10.1016\/j.autrev.2017.07.002_bb0585","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2016.10.003","article-title":"Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis","volume":"77","author":"Chung","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2017.07.002_bb0590","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0595","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1478-3231.2006.01325.x","article-title":"Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M","volume":"26","author":"Harada","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2017.07.002_bb0600","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI0214698","article-title":"Quantitative and functional analysis of PDC-E2\u2013specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis","volume":"109","author":"Kita","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2017.07.002_bb0605","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1073\/pnas.87.10.3987","article-title":"Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region","volume":"87","author":"Fussey","year":"1990","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2017.07.002_bb0610","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/358377a0","article-title":"Molecular mimicry in liver disease","volume":"358","author":"Burroughs","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.07.002_bb0615","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human \u03b2-tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"Terjung","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2017.07.002_bb0620","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-065X.2010.00911.x","article-title":"The metabolic life and times of a T-cell","volume":"236","author":"Michalek","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2017.07.002_bb0625","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nri1710","article-title":"Fuel feeds function: energy metabolism and the T-cell response","volume":"5","author":"Fox","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0630","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/gut.52.10.1442","article-title":"Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts","volume":"52","author":"Willemsen","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2017.07.002_bb0635","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.07.002_bb0640","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.07.002_bb0645","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nutres.2008.02.012","article-title":"Butyrate and trichostatin A attenuate nuclear factor \u03baB activation and tumor necrosis factor \u03b1 secretion and increase prostaglandin E 2 secretion in human peripheral blood mononuclear cells","volume":"28","author":"Usami","year":"2008","journal-title":"Nutr Res"},{"key":"10.1016\/j.autrev.2017.07.002_bb0650","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1073\/pnas.1322269111","article-title":"The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition","volume":"111","author":"Chang","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2017.07.002_bb0655","doi-asserted-by":"crossref","first-page":"27601","DOI":"10.1074\/jbc.M110.102947","article-title":"Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases","volume":"285","author":"Singh","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.07.002_bb0660","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2009.02.046","article-title":"Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells","volume":"137","author":"Eksteen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0665","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","article-title":"Retinoic acid imprints gut-homing specificity on T cells","volume":"21","author":"Iwata","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.07.002_bb0670","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","article-title":"Induction of colonic regulatory T cells by indigenous Clostridium species","volume":"331","author":"Atarashi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.07.002_bb0675","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2017.07.002_bb0680","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2009.08.020","article-title":"The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses","volume":"31","author":"Gaboriau-Routhiau","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.07.002_bb0685","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","article-title":"Th17 cell induction by adhesion of microbes to intestinal epithelial cells","volume":"163","author":"Atarashi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2017.07.002_bb0690","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0695","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0140-6736(59)90098-4","article-title":"The liver in ulcerative colitis treatment of pericholangitis with tetracycline","volume":"274","author":"Rankin","year":"1959","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.07.002_bb0700","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/389537","article-title":"Role of the microbiota and antibiotics in primary sclerosing cholangitis","volume":"2013","author":"Tabibian","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.autrev.2017.07.002_bb0705","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.aad9358","article-title":"Antibiotic use and its consequences for the normal microbiome","volume":"352","author":"Blaser","year":"2016","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.autrev.2017.07.002_bb0710","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1194\/jlr.M075143","article-title":"Comprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodents","volume":"58","author":"Watanabe","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.autrev.2017.07.002_bb0715","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-4274(99)00113-7","article-title":"Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate","volume":"108","author":"Bernstein","year":"1999","journal-title":"Toxicol Lett"},{"issue":"16","key":"10.1016\/j.autrev.2017.07.002_bb0720","doi-asserted-by":"crossref","first-page":"E1610","DOI":"10.1073\/pnas.1401941111","article-title":"Bile salts act as effective protein-unfolding agents and instigators of disulfide stress in vivo","volume":"111","author":"Cremers","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2017.07.002_bb0725","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/gut.39.4.587","article-title":"Role of the gut in the pathophysiology of extrahepatic biliary obstruction","volume":"39","author":"Clements","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2017.07.002_bb0730","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.07.002_bb0735","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1053\/j.gastro.2008.12.040","article-title":"Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium","volume":"136","author":"D'Aldebert","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0740","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000371687","article-title":"Interactions between diet, bile acid metabolism, gut microbiota, and inflammatory bowel diseases","volume":"33","author":"Devkota","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.autrev.2017.07.002_bb0745","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcimb.2014.00009","article-title":"Listeria monocytogenes: survival and adaptation in the gastrointestinal tract","volume":"4","author":"Gahan","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0750","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0755","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1128\/AEM.62.2.656-661.1996","article-title":"Tauroconjugation of cholic acid stimulates 7 alpha-dehydroxylation by fecal bacteria","volume":"62","author":"Van Eldere","year":"1996","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0760","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.autrev.2017.07.002_bb0765","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1194\/jlr.M020313","article-title":"Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7\u03b1-dehydroxylating intestinal bacterium","volume":"53","author":"Ridlon","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.autrev.2017.07.002_bb0770","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2017.07.002_bb0775","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0780","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsbmb.2011.08.002","article-title":"Hydroxysteroid dehydrogenases (HSDs) in bacteria\u2013a bioinformatic perspective","volume":"129","author":"Kisiela","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0785","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000450908","article-title":"Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease","volume":"35","author":"Gonzalez","year":"2017","journal-title":"Dig Dis"},{"key":"10.1016\/j.autrev.2017.07.002_bb0790","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.autrev.2017.07.002_bb0795","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2017.07.002_bb0800","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.autrev.2017.07.002_bb0805","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.celrep.2014.02.032","article-title":"Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice","volume":"7","author":"Degirolamo","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2017.07.002_bb0810","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/19490976.2015.1005474","article-title":"Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242","volume":"6","author":"Martoni","year":"2015","journal-title":"Gut Microbes"},{"key":"10.1016\/j.autrev.2017.07.002_bb0815","first-page":"16A-7A","article-title":"First-in-human experience with LJN452, an orally available non-bile acid FXR agonist, demonstrates potent activation of FXR in healthy subjects","author":"Badman","year":"2016"},{"issue":"2","key":"10.1016\/j.autrev.2017.07.002_bb0820","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/S0168-8278(16)01674-3","article-title":"The non-steroidal Fxr agonist Gs-9674 reduces liver fibrosis and ameliorates portal hypertension in a rat nash model","volume":"64","author":"Schwabl","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0825","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.24537","article-title":"Dual farnesoid X receptor\/TGR5 agonist INT-767 reduces liver injury in the Mdr2\u2212\/\u2212(Abcb4\u2212\/\u2212) mouse cholangiopathy model by promoting biliary HCO 3\u2212 output","volume":"54","author":"Baghdasaryan","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0830","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129866","article-title":"Impaired itching perception in murine models of cholestasis is supported by dysregulation of GPBAR1 signaling","volume":"10","author":"Cipriani","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.07.002_bb0835","first-page":"263A","article-title":"NGM282, a novel variant of FGF-19, demonstrates biologic activity in primary biliary cirrhosis patients with an incomplete response to ursodeoxycholic acid: results of a phase 2 multicenter, randomized, double blinded, placebo controlled trial","volume":"62","author":"Mayo","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0840","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/S0168-8278(16)01696-2","article-title":"Development of a new hepatoprotective and proregenerative molecule based on fibroblast growth factor 15\/19","volume":"64","author":"\u00c1lvarez-Sola","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0845","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0850","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ajg.2015.20","article-title":"A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia","volume":"110","author":"Hosonuma","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0855","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/S0168-8278(16)00146-X","article-title":"Clarity: a phase 2, randomized, double-blind, placebo-controlled study of Lopixibat chloride (formerly Lum001), a novel apical sodium-dependent bile acid transporter inhibitor, in the treatment of primary biliary cirrhosis associated with itching","volume":"64","author":"Mayo","year":"2016","journal-title":"J Hepatol"},{"issue":"10074","key":"10.1016\/j.autrev.2017.07.002_bb0860","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0140-6736(17)30319-7","article-title":"Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study","volume":"389","author":"Hegade","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.07.002_bb0865","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.27973","article-title":"Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice","volume":"63","author":"Miethke","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0870","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.27694","article-title":"Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na+-taurocholate cotransporting polypeptide knockout mice","volume":"62","author":"Slijepcevic","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0875","first-page":"111A-A","article-title":"norUrsodeoxycholic acid (norUDCA) improves cholestasis in primary sclerosing cholangitis (PSC) independent of ursodeoxycholic acid (UDCA) pre-treatment and response","author":"Trauner","year":"2016"},{"key":"10.1016\/j.autrev.2017.07.002_bb0880","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"Liver EAFTSOT","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0885","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.23821","article-title":"The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Kuiper","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0890","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/ecco-jcc\/jjv204","article-title":"Characterization of intestinal microbiota in ulcerative colitis patients with and without primary sclerosing cholangitis","volume":"10","author":"Kevans","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2017.07.002_bb0895","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apt.13552","article-title":"The features of mucosa-associated microbiota in primary sclerosing cholangitis","volume":"43","author":"Torres","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.autrev.2017.07.002_bb0900","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2017.07.002_bb0905","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.autrev.2017.07.002_bb0910","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","article-title":"Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis","volume":"66","author":"R\u00fchlemann","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2017.07.002_bb0915","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","article-title":"The gut-adherent microbiota of PSC\u2013IBD is distinct to that of IBD","volume":"66","author":"Quraishi","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2017.07.002_bb0920","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/imj.1965.14.4.286","article-title":"Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis","volume":"14","author":"Mistilis","year":"1965","journal-title":"Australas Ann Med"},{"key":"10.1016\/j.autrev.2017.07.002_bb0925","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","article-title":"Treatment of pruritus in primary biliary cirrhosis with rifampin: results of a double-blind, crossover, randomized trial","volume":"94","author":"Ghent","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0930","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0935","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1440-1746.1998.tb00740.x","article-title":"Case report: three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine","volume":"13","author":"Kozaiwa","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0940","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00535-005-1758-x","article-title":"Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis","volume":"41","author":"Tada","year":"2006","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0945","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/00005176-199811000-00015","article-title":"Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease","volume":"27","author":"Cox","year":"1998","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.autrev.2017.07.002_bb0950","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.12232","article-title":"Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis-a pilot study","volume":"37","author":"Tabibian","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2017.07.002_bb0955","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"F\u00e4rkkil\u00e4","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2017.07.002_bb0960","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/039463200702000423","article-title":"Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation","volume":"20","author":"Boner","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0965","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ajg.2008.14","article-title":"Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study","volume":"104","author":"Silveira","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.autrev.2017.07.002_bb0970","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/MJT.0000000000000102","article-title":"Prospective clinical trial of rifaximin therapy for patients with primary sclerosing cholangitis","volume":"24","author":"Tabibian","year":"2017","journal-title":"Am J Ther"},{"key":"10.1016\/j.autrev.2017.07.002_bb0975","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MEG.0b013e3282f5197e","article-title":"Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study","volume":"20","author":"Vleggaar","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2017.07.002_bb0980","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000338834","article-title":"Successful treatment of primary sclerosing cholangitis with a steroid and a probiotic","volume":"6","author":"Shimizu","year":"2012","journal-title":"Case Rep Gastroenterol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T12:56:49Z","timestamp":1659185809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":196,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1568997217301702"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.002","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}